Psychiatric symptomatology and health-related quality of life in children and adolescents with alopecia areata

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue 11, 2014, Pages 1463-1468

  Bilgic O ^a   Bilgic A ^b   Bahali K ^c   Bahali, A G ^d   Gurkan A ^e   Yilmaz S ^b  

^a SELCUK UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

^c BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^e Dr Sami Ulus Children's Health and Diseases Training and Research Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADOLESCENT DISEASE; ADULT; ALOPECIA AREATA; ANXIETY; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; QUALITY OF LIFE; QUESTIONNAIRE; SCHOOL CHILD; SOCIAL PSYCHOLOGY; SYMPTOMATOLOGY;

EID: 85006371058     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12315     Document Type: Article

References (30)

1. Ruiz-Doblado S, Carrizosa A, Garcia-Hernandez MJ. Alopecia areata: psychiatric comorbidity and adjustment to illness. Int J Dermatol 2003; 42: 434–437.
2. Manolache L, Benea V. Stress in patients with alopecia areata and vitiligo. J Eur Acad Dermatol Venereol 2007; 21: 921–928.
3. Chu SY, Chen YJ, Tseng WC et al. Psychiatric comorbidities in patients with alopecia areata in Taiwan: a case-control study. Br J Dermatol 2012; 166: 525–531.
4. Koo JY, Shellow WV, Hallmann CP, Edwards JE. Alopecia areata and increased prevalence of psychiatric disorders. Int J Dermatol 1994; 33: 849–850.
5. Ghajarzadeh M, Ghiasi M, Kheirkhah S. Associations between skin diseases and quality of life: a comparison of psoriasis, vitiligo, and alopecia areata. Acta Med Iran 2012; 50: 511–515.
6. Dubois M, Baumstarck-Barrau K, Gaudy-Marqueste C et al. Quality of life in alopecia areata: a study of 60 cases. J Invest Dermatol 2010; 130: 2830–2833.
7. Liakopoulou M, Alifieraki T, Katideniou A et al. Children with alopecia areata: psychiatric symptomatology and life events. J Am Acad Child Adolesc Psychiatry 1997; 36: 678–684.
8. Ghanizadeh A. Environmental stress but not subjective distress in children or adolescents with alopecia areata. Int J Dermatol 2008; 47: 1118–1120.
9. Reeve EA, Savage TA, Bernstein GA. Psychiatric diagnoses in children with alopecia areata. J Am Acad Child Adolesc Psychiatry 1996; 35: 1518–1522.
10. Díaz-Atienza F, Gurpegui M. Environmental stress but not subjective distress in children or adolescents with alopecia areata. J Psychosom Res 2011; 71: 102–107.
11. Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol 2006; 155: 145–151.
12. Weber MB, Lorenzini D, Reinehr CP, Lovato B. Assessment of the quality of life of pediatric patients at a center of excellence in dermatology in southern Brazil. An Bras Dermatol 2011; 87: 697–702.
13. Olsen E, Hordinsky M, McDonald-Hull S et al. Alopecia areata investigational assessment guidelines: National Alopecia Areata Foundation. J Am Acad Dermatol 1999; 40: 242–246.
14. Kovacs M. Rating scale to assess depression in school aged children. Acta Paedopsychiatr 1981; 46: 305–315.
15. Öy B. Children's depression inventory: validity and reliability study (In Turkish). Turk Psikiyatri Derg 1991; 2: 132–136.
16. Spielberger CD. Manual for the state-trait anxiety inventory for children. Consulting Psychologists Press, Palo Alto, 1973.
17. Özusta S. Turkish standardization, reliability and validity of State Trait Anxiety Inventory for children (In Turkish). Turk J Psychol 1995; 10: 32–44.
18. Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care 1999; 37: 126–139.
19. Cakin Memik N, Agaoglu B, Coskun A, Karakaya I. The validity and reliability of Pediatric Quality of Life Inventory in 8–12 year old Turkish children (in Turkish) Turk J Child Adolesc Mental Health 2008;15: 87–98.
20. Cakın Memik N, Agaoglu B, Coskun A et al. The validity and reliability of the Turkish Pediatric Quality of Life Inventory for children 13–18 years old. Turk Psikiyatri Derg 2007; 18: 353–363.
21. Yuan KH. Fit indices versus test statistics. Multivar Behav Res 2005; 40: 115–148.
22. Tabachnick BG, Fidell LS. Using Multivariate Statistics, 5th edn. Allyn and Bacon, New York, 2007.
23. Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model 1999; 6: 1–55.
24. Fan X, Thompson B, Wang L. Effects of sample size, estimation methods, and model specification on structural equation modeling fit indexes. Struct Equ Model 1999; 6: 56–83.
25. Gülec¸ AT, Tanriverdi N, Dürü C, Saray Y, Akçali C. The role of psychological factors in alopecia areata and the impact of the disease on the quality of life. Int J Dermatol 2004; 43: 352–356.
26. Bilgic A, Bilgic Ö, Kaya Akış H, Eskioğlu F, Kılıç EZ. Psychiatric symptoms and health related quality of life in children and adolescents with psoriasis. Pediatr Dermatol 2010; 27: 614–617.
27. Bilgic Ö, Bilgic A. Kaya Akış H, Eskioğlu F, Kılıç EZ. Depression, anxiety and health-related quality of life in children and adolescents with vitiligo. Clin Exp Dermatol 2011; 36: 360–365.
28. Kostopoulou P, Jouary T, Quintard B et al. Objective vs. subjective factors in the psychological impact of vitiligo: the experience from a French referral centre. Br J Dermatol 2009; 161: 128–133.
29. Fortune DG, Main CJ, O'Sullivan TM, Griffiths CE. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 1997; 137: 755–760.
30. Reid EE, Haley AC, Borovicka JH et al. Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia. J Am Acad Dermatol 2012; 66: e97–e102.